A detailed history of Pacific Capital Wealth Advisors, Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Pacific Capital Wealth Advisors, Inc holds 605 shares of LLY stock, worth $481,380. This represents 0.09% of its overall portfolio holdings.

Number of Shares
605
Previous 574 5.4%
Holding current value
$481,380
Previous $519,000 3.08%
% of portfolio
0.09%
Previous 0.09%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$772.14 - $960.02 $23,936 - $29,760
31 Added 5.4%
605 $535,000
Q2 2024

Aug 06, 2024

BUY
$724.87 - $909.04 $99,307 - $124,538
137 Added 31.35%
574 $519,000
Q1 2024

May 15, 2024

BUY
$592.2 - $792.28 $7,698 - $10,299
13 Added 3.07%
437 $339,000
Q3 2023

Nov 03, 2023

BUY
$434.7 - $599.3 $184,312 - $254,103
424 New
424 $227,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Pacific Capital Wealth Advisors, Inc Portfolio

Follow Pacific Capital Wealth Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacific Capital Wealth Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Pacific Capital Wealth Advisors, Inc with notifications on news.